Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl DL-cysteinate hydrochloride is a chemical compound derived from the amino acid cysteine, which is an essential component of proteins and plays a crucial role in metabolism and antioxidant defenses. methyl DL-cysteinate hydrochloride is characterized by its ability to protect against oxidative stress and has demonstrated potential therapeutic roles in conditions related to cysteine metabolism and antioxidant imbalances. Its diverse chemical properties and potential health benefits make it a valuable compound in the pharmaceutical and biotechnology industries.

5714-80-7

Post Buying Request

5714-80-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5714-80-7 Usage

Uses

Used in Pharmaceutical Industry:
Methyl DL-cysteinate hydrochloride is used as a precursor for the production of the antioxidant glutathione, which is vital for maintaining cellular health and combating oxidative stress.
Used in Biotechnology Industry:
1. Methyl DL-cysteinate hydrochloride is used as a chiral resolving agent, which is essential for the separation of enantiomers in various chemical and pharmaceutical processes.
2. It serves as a substrate in the production of cysteine-based drugs, contributing to the development of novel therapeutic agents targeting specific conditions.
Used in Research:
Methyl DL-cysteinate hydrochloride is utilized in research for its potential protective effects against oxidative stress and its possible therapeutic roles in conditions involving cysteine metabolism and antioxidant imbalances, providing insights into the development of new treatments and interventions.

Check Digit Verification of cas no

The CAS Registry Mumber 5714-80-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,1 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5714-80:
(6*5)+(5*7)+(4*1)+(3*4)+(2*8)+(1*0)=97
97 % 10 = 7
So 5714-80-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H9NO2S.ClH/c1-7-4(6)3(5)2-8;/h3,8H,2,5H2,1H3;1H

5714-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-amino-3-sulfanylpropanoate,hydrochloride

1.2 Other means of identification

Product number -
Other names L-CYSTEINE METHYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5714-80-7 SDS

5714-80-7Relevant articles and documents

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Zhang, Yong-Kang,Plattner, Jacob J.,Easom, Eric E.,Jacobs, Robert T.,Guo, Denghui,Freund, Yvonne R.,Berry, Pamela,Ciaravino, Vic,Erve, John C. L.,Rosenthal, Philip J.,Campo, Brice,Gamo, Francisco-Javier,Sanz, Laura M.,Cao, Jianxin

, p. 5889 - 5908 (2017/07/22)

Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, in vivo efficacy, and safety profile. This optimization effort discovered 46, which met our target candidate profile. Compound 46 had excellent activity against cultured Plasmodium falciparum, and in vivo against P. falciparum and P. berghei in infected mice. It exhibited good PK properties in mice, rats, and dogs. It was highly active against the other 11 P. falciparum strains, which are mostly resistant to chloroquine and pyrimethamine. The rapid parasite in vitro reduction and in vivo parasite clearance profile of 46 were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials. It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg. The combined properties of this novel benzoxaborole support its progression to preclinical development.

Synthesis and antibacterial activities of Yanglingmycin analogues

Li, Long-Bo,Dan, Wen-Jia,Tan, Fang-Fang,Cui, Li-Hui,Yuan, Zhi-Peng,Wu, Wen-Jun,Zhang, Ji-Wen

, p. 33 - 37 (2015/01/30)

The synthesis of Yanglingmycin and its enantiomer, along with eighteen Yanglingmycin analogues is reported. The structures were confirmed mainly by analyses of NMR spectral data. Antibacterial activity assays showed that Yanglingmycin and some of its analogues exhibited significant antibacterial activities against two important agricultural pathogenic bacteria, Ralstonia solanacearum and Pseudomonas syringae pv. actinidiae, with minimum inhibitory concentration (MIC) values ranging from 3.91 to 15.62 μg/mL. The antibacterial activities exhibited by Yanglingmycin and its analogues are promising, suggesting potential in the development of compounds for novel bactericides.

Cycloforskamide, a cytotoxic macrocyclic peptide from the sea slug Pleurobranchus forskalii

Tan, Karen Co,Wakimoto, Toshiyuki,Takada, Kentaro,Ohtsuki, Takashi,Uchiyama, Nahoko,Goda, Yukihiro,Abe, Ikuro

, p. 1388 - 1391 (2013/08/23)

A macrocylic dodecapeptide, cycloforskamide, was isolated from the sea slug Pleurobranchus forskalii, collected off Ishigaki Island, Japan. Its planar structure was deduced by extensive NMR analyses and was further confirmed by MS/MS fragmentation analyses. Finally, the absolute configuration was determined by total hydrolysis and chiral-phase gas chromatographic analysis. This novel dodecapeptide contains three d-amino acids and three thiazoline heterocycles and exhibits cytotoxicity against murine leukemia P388 cells, with an IC 50 of 5.8 μM.

A convenient synthesis of amino acid methyl esters

Li, Jiabo,Sha, Yaowu

, p. 1111 - 1119 (2008/09/21)

A series of amino acid methyl ester hydrochlorides were prepared in good to excellent yields by the room temperature reaction of amino acids with methanol in the presence of trimethylchlorosilane. This method is not only compatible with natural amino acids, but also with other aromatic and aliphatic amino acids.

Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer

Gududuru, Veeresa,Hurh, Eunju,Dalton, James T.,Miller, Duane D.

, p. 2584 - 2588 (2007/10/03)

To improve the selectivity and antiproliferative activity of previously reported serine amide phosphates (SAPs), we designed a new series of 4-thiazolidinone amides, in which the 4-thiazolidinone moiety was introduced as a phosphate mimic. However, these 4-thiazolidinone derivatives demonstrated less cytotoxicity in prostate cancer cells despite improved selectivity over RH7777 cells. To further optimize the thiazolidinone analogues in terms of cytotoxicity and selectivity, we made closely related structural modifications, which led us to the discovery of a new class of 2-arylthiazolidine-4-carboxylic acid amides. These compounds were potent cytotoxic agents with IC50 values in the low micromolar concentration range and demonstrated enhanced selectivity in receptor-negative cells compared to SAPs and 4-thiazolidinone amides.

THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF

-

Page/Page column 27-28, (2008/06/13)

Substituted thiazolidinone carboxylic acid amides and substituted thiazolidine carboxylic acid amides according to formulae (I) and (II) are disclosed where the various substituent groups are as defined in the specification. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.

Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation

-

, (2008/06/13)

Novel compounds having activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful in vitro for monitoring plasminogen activator levels and in vivo in treatment of conditions which are ameliorated by inhibition of or decreased activity of urokinase and in treating pathologic conditions wherein blood vessel formation is related to a pathologic condition.

Inhibitors of protein isoprenyl transferases

-

, (2008/06/13)

Compounds having the formula or a pharmaceutically acceptable salt thereof wherein R1 is (a) hydrogen, (b) loweralkyl, (c) alkenyl, (d) alkoxy, (e) thioalkoxy, (f) halo, (g) haloalkyl, (h) aryl-L2—, and (i) heterocyclic-L2—; R2 is selected from (a) (b) —C(O)NH—CH(R14)—C(O)OR15, (c) (d) —C(O)NH—CH(R14)—C(O)NHSO2R16 (e) —C(O)NH—CH(R14)-tetrazolyl, (f) —C(O)NH-heterocyclic, and (g) —C(O)NH—CH(R14)—C(O)NR17R18; R3 is heterocyclic, aryl, substituted or unsubstituted cycloalkyl; R4 is hydrogen, lower alkyl, haloalkyl, halogen, aryl, arylakyl, heterocyclic, or (heterocyclic)alkyl; L1 is absent or is selected from (a) —L4—N(R5)—L5—, (b) —L4—O—L5—, (c) —L4—S(O)n—L5— (d) —L4-L6—C(W)—N(R5)—L5—, (e) —L4-L6—S(O)m—N(R5)—L5—, (f) —L4—N(R5)—C(W)—L7-L5—, (g) —L4—N(R5)—S(O)p—L7—L5—, (h) optionally substituted alkylene, (i) optionally substituted alkenylene, and (j) optionally substituted alkynylene are inhibitors of protein isoprenyl transferases. Also disclosed are protein isoprenyl transferase inhibiting compositions and a method of inhibiting protein isoprenyl transferases.

Chiral molecular recognition in monolayers of diastereomeric N-acylamino acid methyl esters at the air/water interface

Heath, Jonathan G.,Arnett, Edward M.

, p. 4500 - 4514 (2007/10/02)

This article continues our study of the effects of headgroup geometry and temperature on chiral recognition in the force-area isotherms, thermodynamics of spreading, and surface shear viscosities of monolayers and mixed monolayers of long-chain amino acid ester surfactants. N-Stearoyl - and lauroyl - derivatives of the methyl esters of cysteine, cystine, and threonine are compared to the previously-reported serine derivative. The structural points at issue are as follows: (a) the effects of replacing the hydroxyl group of serine with the thiol group of cysteine; (b) the effect of joining two cysteine groups through their sulfur atoms to produce the two-chain cystine surfactant; and (c) the effect of attaching a methyl group to the carbon bearing the hydroxyl group in stearoylserine methyl ester (SSME) to produce the bulkier stearoylthreonine methyl ester (STME). Comparison is first made for the melting point versus enantiomer composition of the crystals for each compound. In all four cases a racemate is formed. Next, the corresponding effects of enantiomeric composition versus the appropriate surface properties are presented and behavior similar to the melting point curves is seen, implying stereoselective behavior when the monolayers are in equilibrium with their crystals or quasicrystalline condensed surface phases. Diastereomeric effects were small, since meso-dilauroylcystine dimethyl ester (DLCDME) showed properties which were nearly identical to its D and L enantiomers, and the allo form of STME was similar to its enantiomers. All four compounds showed distinctly different force-area curves for their enantiomers versus their racemic mixtures, but the shapes of the curves and phase behavior (between liquid-expanded and liquid-condensed films) depended heavily on temperature. All force-area curves show hysteresis effects in the difference between the compression and expansion regions, indicating, as we have shown before, that relaxation of compressed monolayer states is slow and that the films are in metastable states. Phase behavior is an erratic function of headgroup and temperature. Also, there is no general pattern of whether racemates or enantiomers are most expanded. No crystals of quality sufficient for X-ray analysis could be grown, so rigorous interpretation of properties and behavior in terms of structure cannot be made. However, clear differences between the behavior of stearoylcysteine methyl ester (SCME) and SSME can be interpreted in terms of hydrogen bonding of the serine hydroxyl group to the water subphase. Furthermore, comparison of force-area curves for a series of diastereomeric mixtures of L-STME and L-allo-STME with D- and L-SSME suggests that the stereochemistry at the carbon between the ester and amide functions is primarily responsible for the stereoselectivity in the packing of STME films. Films of SCME were too condensed to allow a surface viscosity study, but those of DLCDME and STME exhibited Newtonian flow with essentially no stereoselectivity in their flow properties.

A γ-LACTAM ANALOGUE OF THE PENEMS POSSESSING ANTIBACTERIAL ACTIVITY

Baldwin, Jack E.,Freeman, Richard T.,Lowe, Christopher,Schofield, Christopher J.,Lee, Eun

, p. 4537 - 4550 (2007/10/02)

The synthesis of a γ-lactam analogue of penems, from aspartic acid semi-aldehyde, which possessed antibacterial activity is described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5714-80-7